For men with intermediate-risk prostate cancer, a trial reveals improvements in several clinical outcomes.

Published Date: 03 May 2023

The primary endpoint of the phase 3 NRG Oncology RTOG 0815 clinical study, which compared dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term androgen deprivation (STAD), was not met.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?

2.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

3.

Biomarker panel offers hope for early pancreatic cancer detection

4.

Financial hardship common in patients with cancer

5.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot